CCO Shares The Calmer Co International Limited
ASX · ASXLast in our picks 2026-10-21 — not in the current list; analysis below is from that screen
Wellness-product expansion could accelerate growth, but valuation and liquidity remain speculative.
Future value: $0.00 (+100.00%) · 6-12 months
Signal breakdown
- ▸New-product potential without confirmed institutional accumulation.
- ▾Below 50-day MA (0%)
- ▾Near 52-week low (0% of range)
- ▸~100% upside to price target
Is CCO a buy right now?
Trend: CCO is trading RSI 48 — neutral momentum, with a 3-month return of +0.00%.
Valuation & quality: fundamentals show net margin -46.9%, return on equity -524.6%, revenue growth 0.3% year on year.
Our screen: ACCUMULATE (score 1) — Wellness-product expansion could accelerate growth, but valuation and liquidity remain speculative.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — |
Fundamentals
Technical signals
About The Calmer Co International Limited
The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It operates through four segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan.
Sector: Consumer Defensive · Industry: Packaged Foods · Australia · Website
Related Consumer Staples picks
Browse: all ASX stocks · Consumer Staples picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.